Dr. Michael Ye is a Partner in the firm’s Intellectual Property practice. Dr. Ye has extensive experience in patent prosecution, opinion work, due diligence and licensing, as well as trademark prosecution and licensing, and copyright. Dr. Ye has handled drafting and prosecuting patent applications globally, inter partes review and post grant proceedings, product clearance searches, product evaluations, inventorship analysis, non-disclosure agreements and licensing agreements. He has substantial experience across the breadth of life sciences, in particular in biotechnology, chemistry/organic chemistry, bioinformatics, cosmetics, pharmaceuticals, medical devices, agriculture and artificial intelligence.
Dr. Ye is named among the worlds leading patent practitioners in IAM Patent 1000, the top worldwide guide to leading patent professionals and firms. Dr. Ye has extensive experience in inbound and outbound negotiations and business transactions in China. His cultural sensitivities, linguistics capabilities and technical expertise enhance his successful prosecution, opinion, due diligence and licensing work. Dr. Ye focuses on securing commercially valuable claims that align with clients business strategies, as well as identifying and developing licensing opportunities globally. He provides advice and strategic overview regarding management and development of patent portfolios, including advice on licensing and trademarks.
Prior to legal practice, Dr. Ye was a professor of biochemistry and molecular biology at George Washington University and Children’s National Medical Center from 1997 to 2002. His research experience included areas such as gene therapy, transgenics, immune response and vaccine development.
Dr. Ye has authored or co-authored 28 peer-reviewed scientific articles, including an article in the prestigious journal Science. He was the recipient of the National Institutes of Health’s National Research Service Award and the recipient of the Award for Scientific and Academic Achievement from the Children’s Medical Center.
Awards and Recognition
- IAM Patent 1000: Patent Prosecution, 2016, 2017, 2020, 2021
- Chambers USA, Intellectual Property: Patent Prosecution, 2021
- Coronavirus Drug Shows Global Hurdles to Patent Protection, Co-Author, Law360, February 2020
- New USPTO Guidance May Help Diagnostics Patents, Co-Author, Law360, April 2019
- New Proposed Rules Regarding Government Rights in Federally Funded Research: Bayh-Dole Act, Co-Author, The National Law Review, February 21, 2017
- The Myriad Decision in the U.S. Supreme Court, Co-Author, The National Law Review, July 11, 2012
- Is an Isolated DNA Patentable?, Co-Author, The National Law Review, October 27, 2011